AEDs for COVID-related

Cardiac Arrests

Be prepared for a surge in cardiac arrests related to COVID-19

 

As quarantine orders are lifted and people start to resume their normal activities, Philips is focused on protecting community members who have leftover heart damage caused by COVID-19. Having a Philips HeartStart OnSite or HeartStart FRx AED on hand gives added peace of mind for people with compromised hearts.

The statistics below illustrate how COVID-19 can affect weakened hearts.

78% of people diagnosed with Covid-19
Cardiac complications
Arrhythmia is a top 3 risk
21% of ICU patients

Add peace of mind with the Philips HeartStart OnSite or FRx AED

 

With you every step of the way, Philips has been right here from the start in an effort to help healthcare workers on the frontlines treat patients with COVID-19. The Philips HeartStart OnSite and HeartStart FRx AEDs are with you every step of the way by guiding you through the process of treating a victim of suspected sudden cardiac arrest with real-time instructions, step-by-step voice commands, and CPR

guidance.

HeartStart HS1 and FRx

With two-million AEDs sold around the world, Philips AEDs can be found on board major U.S. airlines, in Fortune 100 companies, and in the locker rooms of professional sports teams. Learn why Philips is the leader in AEDs and discover which AED is right for you. 

Step-by-step guidance with voice instructions, CPR and visual icons

Designed for the ordinary person in an extraordinary moment

For use on children and adults and available without a prescription

Performs automatic self-tests so the AED is ready to use

Real-time, step-by-step voice commands assist the first responder

Can withstand rough handling, extreme temperatures, and dusty or wet surface

For use on infants and children

Performs automatic self-tests so the AED is ready to use

Get started with AEDs

Fill out a short form and an AED expert will reach out to you as soon as possible.

Learn more about why Philips is the leader in AEDs  

Youtube video for AED
*

Contact information

* This field is mandatory

*
*
*
*
*
*
*
*
*

By specifying your reason for contact we will be able to provide you with a better service.

We work with partners and distributors who may contact you about this Philips product on our behalf.

*
*

Final CEE consent

1. Three-quarters of adults with COVID-19 have heart damage after recovery https://www.sca-aware.org/sca-news/three-quarters-of-adults-with-covid-19-have-heart-damage-after-recovery

2. Twenty-one percent of ICU patients globally, hospitalized with COVID-19 had atrial fibrillation. https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-rapid-risk-assessmentcoronavirus-disease-2019-eighth-update-8-april-2020.pdf

3. ACC Clinical Guidance for the CV Care Team. https://www.acc.org/~/m edia/665AFA1E710B4B3293138D 14BE8D1213.pdf

4. Besides myocardial infarction and heart failure, arrhythmias are generally one of the three major risks associated with viral infections, due to myocarditis, proinflammatory effects, and an increased sympathetic stimulation. https://link.springer.com/article/10.1007/s00059-020-04924-0

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.